Esperion Therapeutics Aktie

Kaufen
Verkaufen
2,87 EUR +0,30 EUR +11,87 %
3,22 USD +0,12 USD +3,70 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln! Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO! Bei einem anderen Broker handeln Smartphone

Marktkap. 525,23 Mio. EUR

Div. Rendite 0,00%

WKN A1W1SJ

ISIN US29664W1053

Symbol ESPR


Esperion Therapeutics Aktie Analyse

07.01.19 Esperion Therapeutics Strong Buy Needham & Company, LLC
16.10.18 Esperion Therapeutics Buy BTIG Research
21.02.18 Esperion Therapeutics Strong Buy Needham & Company, LLC
17.01.18 Esperion Therapeutics Buy UBS AG
14.12.17 Esperion Therapeutics Strong Buy Needham & Company, LLC
27.06.17 Esperion Therapeutics Buy Stifel, Nicolaus & Co., Inc.
23.06.17 Esperion Therapeutics Buy Deutsche Bank AG
30.03.17 Esperion Therapeutics Buy UBS AG
30.06.16 Esperion Therapeutics Buy Needham & Company, LLC
25.02.16 Esperion Therapeutics Buy Stifel, Nicolaus & Co., Inc.
15.12.15 Esperion Therapeutics Outperform RBC Capital Markets
26.10.15 Esperion Therapeutics Buy Lake Street
26.10.15 Esperion Therapeutics Buy WallachBeth
19.08.15 Esperion Therapeutics Buy Needham & Company, LLC
10.08.15 Esperion Therapeutics Strong Buy Needham & Company, LLC
21.05.15 Esperion Therapeutics overweight Barclays Capital
08.05.15 Esperion Therapeutics Buy Needham & Company, LLC
08.05.15 Esperion Therapeutics Buy Stifel, Nicolaus & Co., Inc.
23.04.15 Esperion Therapeutics Outperform RBC Capital Markets
01.04.15 Esperion Therapeutics Buy UBS AG
06.03.15 Esperion Therapeutics Buy Needham & Company, LLC
17.02.15 Esperion Therapeutics Buy Stifel, Nicolaus & Co., Inc.
27.10.14 Esperion Therapeutics Buy Needham & Company, LLC